- Home
- ABEO vs JILL Comparison
ABEO vs JILL Comparison
Compare ABEO & JILL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABEO
- JILL
- Stock Information
- Founded
- ABEO 1974
- JILL 1959
- Country
- ABEO United States
- JILL United States
- Employees
- ABEO N/A
- JILL N/A
- Industry
- ABEO Biotechnology: Pharmaceutical Preparations
- JILL Clothing/Shoe/Accessory Stores
- Sector
- ABEO Health Care
- JILL Consumer Discretionary
- Exchange
- ABEO Nasdaq
- JILL Nasdaq
- Market Cap
- ABEO 256.9M
- JILL 233.1M
- IPO Year
- ABEO 1980
- JILL 2017
- Fundamental
- Price
- ABEO $5.57
- JILL $15.39
- Analyst Decision
- ABEO Strong Buy
- JILL Buy
- Analyst Count
- ABEO 6
- JILL 4
- Target Price
- ABEO $18.00
- JILL $29.75
- AVG Volume (30 Days)
- ABEO 1.1M
- JILL 183.4K
- Earning Date
- ABEO 08-11-2025
- JILL 06-11-2025
- Dividend Yield
- ABEO N/A
- JILL 2.06%
- EPS Growth
- ABEO N/A
- JILL N/A
- EPS
- ABEO N/A
- JILL 2.24
- Revenue
- ABEO N/A
- JILL $602,968,000.00
- Revenue This Year
- ABEO N/A
- JILL $1.16
- Revenue Next Year
- ABEO $323.51
- JILL $2.58
- P/E Ratio
- ABEO N/A
- JILL $6.91
- Revenue Growth
- ABEO N/A
- JILL N/A
- 52 Week Low
- ABEO $3.93
- JILL $13.36
- 52 Week High
- ABEO $7.32
- JILL $40.00
- Technical
- Relative Strength Index (RSI)
- ABEO 37.51
- JILL 47.44
- Support Level
- ABEO $5.66
- JILL $13.53
- Resistance Level
- ABEO $6.24
- JILL $15.36
- Average True Range (ATR)
- ABEO 0.26
- JILL 0.75
- MACD
- ABEO -0.08
- JILL 0.08
- Stochastic Oscillator
- ABEO 8.08
- JILL 73.50
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.
About JILL J. Jill Inc.
J.Jill Inc is a national lifestyle brand that provides apparel, footwear, and accessories. The company's products are marketed under the J.Jill brand name and sold through its two channels: its e-commerce platform and catalog (Direct) and its retail stores (Retail). Revenue is derived from the sale of apparel and accessory merchandise through the company's Retail and Direct channels, which include website and catalog phone orders. Revenue also includes shipping and handling fees collected from customers.